Document is current
Any future updates will be listed below
-
Authors
Noonepalle, Satish kumar Reddy
Gracia-Hernandez, Maria
Aghdam, Nima
Berrigan, Michael
Coulibaly, Hawa
Li, Xintang
Zevallos-Delgado, Christian
Pletcher, Andrew
Weselman, Bryan
Palmer, Erica
Knox, Tessa
Sotomayor, Eduardo
Chiappinelli, Katherine B.
Wardrop, Duncan
Horvath, Anelia
Shook, Brett A.
Lee, Norman
Dritschilo, Anatoly
Fernandes, Rohan
Musunuri, Karthik
Shibata, Maho
Villagra, Alejandro
-
Funding
Funding for this research was provided by:
Cancer Research Institute (228514)
National Cancer Institute (R01CA249248)
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 4 September 2024
First Online: 14 September 2024
Declarations
:
: The research conducted in this study was performed as per the IACUC guidelines (Protocol# A354) at George Washington University, Washington DC, USA.
: Not applicable.
: A.D. owns equity and serves as CEO of Shuttle Pharmaceuticals, Inc., Rockville MD. K.M. serves as CEO of Avstera Therapeutics, Malvern PA.
